Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07570615 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development and Validation of a Chinese Quality of Life Scale for Pulmonary Arterial Hypertension

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study aims to develop and validate a culturally appropriate, reliable, and clinically applicable patient-reported outcome (PRO) instrument to assess quality of life in patients with pulmonary arterial hypertension (PAH) in China. The study includes two phases: (1) scale development using literature review, Delphi expert consultation, and patient interviews; and (2) multicenter prospective observational validation to evaluate reliability, validity, and responsiveness. The final scale is expected to support clinical assessment, treatment monitoring, and health policy decision-making.
Trial Details
NCT Number NCT07570615
Lead Sponsor Chinese Pulmonary Vascular Disease Research Group
Conditions
(from sponsor)		 Pulmonary Arterial Hypertension (PAH), Quality of Life, Patients Reported Outcomes
Related terms Pulmonary Arterial Hypertension
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov